title: Three years since the FDA advisory panel on drug-eluting stents: what have we learned about off-label use and stent thrombosis?
authors.affiliation: Department of Medicine, Winthrop University Hospital, 120 Mineola Blvd, Suite 500, Mineola, NY, 11501, USA. ssnaidu@winthrop.org
authors.forename: Srihari S
authors.initials: SS
authors.lastname: Naidu
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D003324:Coronary Artery Disease / Q000628:therapy*; D023903:Coronary Restenosis / Q000453:epidemiology; D003328:Coronary Thrombosis / Q000453:epidemiology*; D054855:Drug-Eluting Stents / Q000009:adverse effects*; D006801:Humans; D056687:Off-Label Use; D012307:Risk Factors; D014481:United States; D014486:United States Food and Drug Administration